Learning Objective
In this e-conference you will learn about new and evolving publishing requirements and how to avoid some of the new barriers to publishing.
New Requirements for Study Publication
In the not so distant past, after completing your clinical study you used the report to get FDA approval and to prepare a manuscript. The journal editors reviewed your manuscript and recommended for or against publication. In today's new environment, publication requirements are being established by the US government (FDA), individual states (Maine), The International Committee of Medical Journal Editors (ICMJE), and international interests such as regulatory authorities and the World Health Organization (WHO).
Medical Journals Require Registration Audience Suitability: Presenter: The purchase is $420 for OnDemand access and $470 for the CD. Event materials are available by download for OnDemand or are on the CD itself. Each attendee is eligible for 0.15 CEUs upon completing the course feedback via the link provided with the event materials. Click here to purchase.
Clinical trial registration is now required by the International Committee of Medical Journal Editors (ICMJE) for all trials if you want to publish the data. You can register with www.clinicaltrials.gov (which may be required by FDA), the International Clinical Trials Registry Platform (ICTRP) managed by WHO, or any of a number of other registries. Our presenter, Ms. Karen Bannick, will provide an overview of the current and historical issues regarding clinical trial publication.
You will receive:
[x] PowerPoint Slides.
[x] An expert speaker.
[x] A chance for Q&A.
[x] Solutions to publication barriers.
[x] CEUs & Certificate.
[x] Clinical research professionals who publish data.
[x] Regulatory professionals who report clinical data.
[x] Statistical professionals who analyze data for publication.
[x] Managers who sign-off on clinical trials.
[x] Marketers who need publications for sales calls.
[x] Executives who are planning the future of their companies
Ms. Karen Bannick founded Bannick Consulting, LLC in 1998. Ms. Bannick has worked in the medical device industry for 17 years and has developed clinical and regulatory strategies for Class II and III products. Her background is unusually broad, encompassing biostatistics, clinical research and regulatory affairs. Using this expertise, she has carved a niche in the industry by preparing manuscripts and abstracts in conjunction with physicians and study groups. Her ability to apply many perspectives to the writing process has proven critical in successfully completing these projects. Ms. Bannick can be reached at karen@bannickconsulting.com
Comments